Medicare Enrolled
Dr. Eddy Mizrahi, MD
Internal Medicine · Horsham, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mizrahi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mizrahi?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mizrahi
Dr. Eddy Mizrahi is an internal medicine specialist in Horsham, PA, with 16 years of NPI registration. Based on federal Medicare data, Dr. Mizrahi performed 1,895 Medicare services across 1,246 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mizrahi received a total of $22,125 from 39 pharmaceutical and/or device companies across 512 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mizrahi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 11% volume in PA
$22,125 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,895
Medicare services
Top 11% in PA for internal medicine
1,246
Unique beneficiaries
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~118 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
382 | $11 | $130 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
361 | $100 | $185 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
337 | $100 | $250 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
266 | $7 | $60 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
227 | $145 | $338 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
86 | $66 | $150 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
49 | $128 | $296 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
45 | $179 | $345 |
| External shock to heart to regulate heart beat A procedure that delivers an electric shock to the heart from outside the body to restore a normal heart rhythm. |
25 | $91 | $1,200 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
21 | $3 | $89 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
20 | $169 | $800 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
20 | $109 | $242 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
15 | $21 | $90 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
14 | $18 | $100 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
14 | $724 | $2,200 |
| Follow-up ultrasound of heart blood flow, valves and chambers An ultrasound exam that follows up on the heart's blood flow, valves, and chambers. It uses sound waves to create images of the heart's structure and function. |
13 | $6 | $25 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.7% high complexity
1.9% medium
96.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$22,125
Total received (2018-2024)
Avg $3,161/year across 7 years
Top 4% in PA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
512
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,835 (76.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$5,290 (23.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$7,125
2023
$2,709
2022
$2,844
2021
$3,574
2020
$1,489
2019
$2,418
2018
$1,966
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$5,290
Merck Sharp & Dohme LLC
$320
Janssen Pharmaceuticals, Inc
$310
Novartis Pharmaceuticals Corporation
$154
AstraZeneca Pharmaceuticals LP
$138
Novo Nordisk Inc
$115
Amgen Inc.
$115
Abbott Laboratories
$112
Teva Pharmaceuticals USA, Inc.
$103
Boston Scientific Corporation
$92
ABIOMED
$92
Impulse Dynamics (USA) Inc.
$56
PFIZER INC.
$40
Medtronic, Inc.
$33
Lexicon Pharmaceuticals, Inc.
$31
Boehringer Ingelheim Pharmaceuticals, Inc.
$28
E.R. Squibb & Sons, L.L.C.
$23
United Therapeutics Corporation
$22
Kiniksa Pharmaceuticals International, plc
$19
La Jolla Pharmaceutical Company
$17
LANTHEUS MEDICAL IMAGING, INC.
$17
Top 3 companies account for 83.1% of 2024 payments
All-time payments by company (2018-2024) ›
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$6,386
Janssen Pharmaceuticals, Inc
$4,250
AstraZeneca Pharmaceuticals LP
$1,770
PFIZER INC.
$1,571
Amgen Inc.
$1,273
Novartis Pharmaceuticals Corporation
$938
Boehringer Ingelheim Pharmaceuticals, Inc.
$930
Abbott Laboratories
$727
Merck Sharp & Dohme LLC
$649
Boston Scientific Corporation
$597
E.R. Squibb & Sons, L.L.C.
$428
Medtronic, Inc.
$308
BOSTON SCIENTIFIC CORPORATION
$291
Akcea Therapeutics, Inc.
$210
Impulse Dynamics (USA) Inc.
$207
Kiniksa Pharmaceuticals, Ltd.
$179
Lantheus Medical Imaging, Inc.
$168
Merck Sharp & Dohme Corporation
$158
ABIOMED
$122
Novo Nordisk Inc
$115
Edwards Lifesciences Corporation
$103
Teva Pharmaceuticals USA, Inc.
$103
Regeneron Healthcare Solutions, Inc.
$79
BIOTRONIK INC.
$79
Amarin Pharma Inc.
$70
Alnylam Pharmaceuticals Inc.
$63
SANOFI-AVENTIS U.S. LLC
$46
Medtronic Vascular, Inc.
$43
Esperion Therapeutics, Inc.
$35
Corcym Inc
$35
Lexicon Pharmaceuticals, Inc.
$31
Davol Inc.
$26
AtriCure, Inc.
$24
Medtronic USA, Inc.
$22
United Therapeutics Corporation
$22
Kiniksa Pharmaceuticals International, plc
$19
La Jolla Pharmaceutical Company
$17
LANTHEUS MEDICAL IMAGING, INC.
$17
Terumo Medical Corporation
$12
Top 3 companies account for 56.1% of all-time payments
Associated products mentioned in payments ›
AMPLATZER Occluders · Arcalyst · Assurity Pacemaker · Azure · BRILINTA · CAMZYOS · CARBOMEDICS CARBO-SEAL VALSALVA · CHANTIX · COBALT DR MRI SURESCAN · CardioMEMS HF System · ClearSight System · Corlanor · DEFINITY · Definity · ELIQUIS · EMBLEM · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edwards SAPIEN 3 Transcatheter Heart Valve · FARXIGA · GENERAL - THERAPIES · GIAPREZA · General - Therapies · INGEVITY · INVOKANA · Impella · JARDIANCE · LEQVIO · LINQ II · LOKELMA · LifeVest · MICRA · MITRACLIP · MULTAQ · Mitra Clip system · NEXLETOL · ONPATTRO · ONYX FRONTIER · OPTIMIZER · Optimizer · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · R2P MISAGO · RESOLUTE ONYX · Renamic Neo · Repatha · Reveal LINQ · SELECTSECURE · Solitaire · TEGSEDI · TELESCOPE · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TYVASO · UZEDY · VERQUVO · VIGILANT · VYNDAQEL · Vascepa · WAINUA · WATCHMAN · WATCHMAN Access System · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (76%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 4% for internal medicine in PA.
Geographic Context
Internal medicine physicians within 10 mi
4,226
Per 100K population
490.7
County median income
$111,521
Nearest hospital
HORSHAM CLINIC
3.3 mi
3.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mizrahi is a clinical cardiology specialist, with above-average Medicare volume (top 11% in PA), with low-engagement industry engagement in the top 4% of PA peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mizrahi experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Mizrahi performed 382 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mizrahi receive payments from pharmaceutical companies?
Yes. Dr. Mizrahi received a total of $22,125 from 39 companies across 512 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mizrahi's costs compare to other internal medicine physicians in Horsham?
Dr. Mizrahi's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mizrahi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Horsham
Browse internal medicine physicians in Horsham ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in PA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in PA
Which PA internal medicine physicians receive the most from drug and device companies.
By company
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) Payments to Doctors
See all physicians who received payments from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp).
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology